DNDN
DNDN Articles
According to Reuters, Goldman Sachs (GS) would like to return to its old businesses and compensation practices, but it may not be able to. Reuters reports that the US is planning to reveal the...
Published:
Last Updated:
Brean Murray comments on Dendreon (Nasdaq: DNDN) this morning, following Friday’s 38% run-up, which they said was related to competitor’s call with a physician in the field and word Provenge...
Published:
The carnage among financial stocks is so complete, that they are listed here witht thier lows: Bank of America (BAC): $5.17, Citigroup (C): $2.80, Wells Fargo (WFC): $14.02, JP Morgan (JPM): $17.70,...
Published:
Last Updated:
These are some of the top analyst upgrades and downgrades we are seeing from Wall Street analysts this Thursday morning: Anadarko Petroleum (APC) Raised to Buy at Jefferies. ATP Oil & Gas (ATPG)...
Published:
Dendreon Corp. (NASDAQ: DNDN) was an incredible performer today, and one which makes you wonder how well it would have done had the stock market not been so ugly. Its interim data from Phase III...
Published:
Last Updated:
After looking through the filing and press release regarding Dendreon Corporation (NASDAQ: DNDN), there are some interesting data points that could be a game changer for current and future investors....
Published:
Last Updated:
Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would note that many of the largest market...
Published:
Biotech’s are sliding along with all the others today. A look at the highlights and outliers: Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that arthritis and psoriasis drug Enbrel will now...
Published:
Most stocks trading under $10 probably traded much higher at one point or another. Trading below that price point is usually not a badge of honor. But, inexpensive stocks often make huge percentage...
Published:
CNBC’s Mike Huckman just announced what is going to be a disappointment for Dendreon (NASDAQ: DNDN) holders, and that may be an understatement. The House Committee will not be forcing any action...
Published:
Last Updated:
Today was a brutal day for risk stocks, and biotechs are often thought of as risky to stocks as Russian Roulette is to your head. But Biotechs are also a source of safety IF they are winners, and...
Published:
Last Updated:
Dendreon Corp. (NASDAQ:DNDN) shares are trading up in early trading on a patent award, and that is after the fairly large gains yesterday. Dendreon was granted a broad European patent covering...
Published:
Last Updated:
Below is a snapshot of the key pre-market news that we are focusing on for early pre-market trading this Tuesday: Apple (AAPL) has its Macworld today. CECO Environmental (CECE) announced 14 new...
Published:
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke...
Published:
Last Updated:
If you read 24/WallSt.com’s "Ten Stocks That Could Double in 2008" from us, you saw that Dendreon (NASDAQ:DNDN) is on that list. We weren’t expecting a 22% pop in shares this fast. We’d...
Published:
Last Updated: